Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.
Clinical trial NCT00151788 · TERMINATED
Trial details
- NCT number
- NCT00151788
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2006-03-01
- Enrollment
- 796
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.